INTRODUCTION
The leukocyte-derived cytokine interferon-␣ (IFN-␣) is currently used as a therapeutic in hematology (chronic myelogenous and hairy cell leukemia), oncology (lymphoma, adjuvant treatment of resected melanoma), and infectious disease (chronic hepatitis B and C) [1] [2] [3] . The precise mechanism underlying the benefit of IFN-␣ in these diseases is not known, but it seems well established that immunostimulatory properties of IFN-␣ contribute to its antineoplastic and antiviral efficiency [3] [4] [5] [6] . These activating properties comprise interalia triggering of tumoricidal and antiviral lymphocytes such as natural killer (NK) cells and cytotoxic T cells. Early studies demonstrated that IFN-␣ induces cytolytic activity in NK cells, expands their target cell spectrum, and induces transcription of cytokine genes and the de novo appearance of activation markers in T cells as well as NK cells. The lymphocyte activation is assumed to result from interaction between IFN-␣ and defined IFN receptors on lymphocytes [7, 8] . More recent studies suggest that IFN-␣ also up-regulates stimulatory molecules on antigen-presenting dendritic cells to indirectly activate cytotoxic lymphocytes [9] .
Phagocytes, in particular, mononuclear phagocytes (MPs), form a major part of the cellular inflammatory infiltrate within human malignant tumors and in chronically infected tissues [10, 11] . These phagocytic cells produce reactive oxygen sepcies (ROS) by assembling and activating a reduced nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase complex at the cell membrane. A first step in the NADPH oxidasedependent formation of ROS is the reduction of oxygen to superoxide anions, which are rapidly metabolized into hydrogen peroxide and other oxygen species. Earlier studies have revealed that phagocyte-derived ROS induce dysfunction and apoptosis of NK cells and T cells [12] [13] [14] [15] [16] , and lymphocyte inhibition by phagocyte-derived ROS has been proposed as an important immune escape mechanism in tumors and in chronically infected tissue (reviewed in refs. [17] [18] [19] ).
Understanding the impact of MPs and in particular, their production of ROS, on the inducibility of cytotoxic lymphocytes by IFN-␣ may therefore have therapeutic implications. CD69 (Leu-23 or MLR-3), a transmembrane glycoprotein with signal-transducing properties, is induced on the surface of T cells or NK cells by IFN-␣, and the CD69 induction correlates to cytotoxicity and proliferation in cytotoxic lymphocytes [20 -22] . In this study, we used the surface expression of CD69 as a marker for IFN-␣-induced activation of cytotoxic lymphocytes and studied the impact of ROS-producing phagocytes on these immunostimulatory events. We report that ROS, constitutively produced by autologous MPs, suppress or abolish IFN-␣ stimulation in NK cells, CD8 ϩ T cells, and NK/T cells, a hybrid of NK and T cells with a CD3ε ϩ /56 ϩ phenotype [23] . In addition to becoming nonresponsive to IFN-␣, a sizable fraction of these cytotoxic lymphocytes acquired features of apoptosis after exposure to ROS-producing phagocytes. Three strategies to circumvent oxidative stress-the NADPH-oxidase inhibitors histamine dihydrochloride and diphenylene iodonium (DPI) and the hydrogen peroxide scavenger catalase-all rescued NK, NK/T, and T cells from MP-induced apoptosis and restored their responsiveness to IFN-␣. We conclude that MP-derived ROS limit the IFN-␣-induced activation of cytotoxic lymphocytes and propose that adjunctive, antioxidative therapy may be useful in enhancing the immunostimulatory efficiency of IFN-␣.
MATERIALS AND METHODS

Separation of mononuclear cells (MNC)
Peripheral venous blood was obtained as freshly prepared leukopacks from healthy blood donors at the Blood Center, Sahlgren's Hospital (Göteborg, Sweden). The blood (65 ml) was mixed with 92.5 ml Iscove's medium, 35 ml 6% Dextran (Kabi Pharmacia, Stockholm, Sweden), and 7.5 ml acid citrate dextrose (Baxter, Deerfield, IL). After incubation for 15 min at room temperature, the supernatant was carefully layered onto Ficoll-Hypaque (Lymphoprep, Nyegaard, Norway). The MNC were collected at the interface after centrifugation at 380 g for 15 min and washed twice in phosphate-buffered saline (PBS) and resuspended in Iscove's medium supplemented with 10% human AB ϩ serum. During all further separation of cells, the cell suspensions were kept in siliconized test tubes (Vacuette, Greiner, Stockholm).
The cells were further separated into lymphocytes and MPs using the counter-current centrifugal elutriation technique, as described in detail elsewhere [12] . Briefly, the MNC were resuspended in elutriation buffer containing 0.05% bovine serum albumin and 0.015% EDTA in buffered NaCl and fed into a Beckman J2-21 ultracentrifuge with a JE-6B rotor at 2100 rpm. A fraction with Ͼ90% MPs was obtained at a flow rate of 18 In some experiments, dynabeads (Dynal A/S, Oslo, Norway) coated with anti-CD56 were used to obtain purified lymphocyte preparations of T cells, as described in detail elsewhere [24] . In some experiments, the lymphocyte fraction was further separated by the FACSAria cell-sorting system obtaining CD3ε ϩ /CD56 ϩ NK/T cells. The mixture of NK and T cells or sorted NK/T cells was exposed to autologous, elutriated MPs in microplates. The lymphocytes (150,000 cells/well in 200 l) were incubated with or without MPs (150,000 cells/well) for 16 h at 37°C.
Assays of apoptosis
Apoptosis was monitored by use of flow cytometry. Nonapoptotic T cells or NK cells were gated after exposure to MPs, as described elsewhere [25] . The gate was set to comprise lymphocytes with reduced forward-scatter and increased right angle-scatter characteristics of apoptosis [16] . The level of apoptosis determined in lymphocytes using this assay was earlier shown to correlate closely with Annexin V staining [15] , analysis of DNA strand breaks by terminal deoxynucleotidyl transferase-mediated bromolated deoxyuridine triphosphate nick end-labeling of DNA fragments [26] , and analysis of reduced intracellular glutathione [16] .
Detection of surface antigens
One million cells were incubated with appropriate fluorescein isothiocyanate (FITC)-, phycoerythrin (PE)-, and peridinin chlorophyll protein (PerCP)-conjugated monoclonal antibodies (mAb; Becton Dickinson, Stockholm, Sweden; 1 l/10 6 cells) on ice for 30 min. The cells were washed twice in PBS and resuspended in 500 l sterile-filtrated PBS and analyzed by use of flow cytometry on a FACSort with a Lysys II software program (Becton Dickinson) or FACSAria cell-sorting system with a CellQuest software program (Becton Dickinson). Lymphocytes were gated on the basis of forward-and right anglescatter. The flow rate was adjusted to Ͻ200 cells ϫ s -1 , and at least 10 4 cells were analyzed for each sample, if not otherwise stated.
Compounds
Human recombinant IFN-␣-2b (IntronA, Schering-Plough, Stockholm, Sweden), histamine dihydrochloride (Maxim Pharmaceuticals, San Diego, CA; Sigma Chemcials, Stockholm, Sweden), ranitidine hydrochloride (Glaxo, Möln-dal, Sweden), AH202399AA (Glaxo), DPI (Sigma Chemical Co., St. Louis, MO), catalase (Boehringer Mannheim, Germany), and L-nitro-arginine-methylester (L-NAME; Sigma Chemical Co.) compounds were readily dissolved in culture medium. FITC-, PE-, and PerCP-conjugated mAb against CD3ε, CD4, CD8, CD56, and CD69 were purchased from Becton Dickinson.
Statistics
For statistical analysis, Mann-Whitney U-test or Wilcoxons sign-rank test was used.
RESULTS
CD69 activation antigen induction in T, NK/T, and NK cells
We determined the expression of CD69 on T, NK/T, and NK cells, incubated in the presence or absence of autologous MPs. 
e a Lymphocytes and MPs were recovered from peripheral blood MNC (PBMC) by centrifugal elutriation. The lymphocytes (150,000 cells/well in a total volume of 200 l) were incubated with or without MPs (150,000 cells/well) and were concomitantly treated with IFN-␣ (100 U/ml), histamine (50 M), or culture medium (control) for 16 h at 37°C. CD69 expression was monitored in indicated subsets of lymphocytes by use of flow cytometry in gates comprising all viable lymphocytes. Data show the percent of respective cells carrying CD69. The data show the mean percentage of CD69 ϩ cells with respective phenotype Ϯ SEM recovered from up to 15 blood donors; b A significant fraction of NK cells carry the CD8 antigen [28] . In studies of CD8 ϩ T cells, CD8 ϩ NK cells were depleted by use of anti-CD56-coated beads, as described elsewhere [13] . Similar results were obtained in experiments in which three-color analysis of CD3ε [27] , T cells with CD3ε, CD4, or CD8 phenotype acquired CD69 when treated with IFN-␣ (100 U/ml) in the absence of MPs. CD69 appeared at 2-4 h after the onset of treatment with IFN-␣ with an expression maximum at 16 -24 
ϩ T cells significantly increased their expression of CD69 after incubation with MPs ( Table 1) Table 1) .
The constitutive expression of CD69 on CD56 ϩ NK cells and CD56
ϩ NK/T cells was significantly higher than that observed in CD4 ϩ or in CD8 ϩ T cells, in concordance with earlier studies [21] . NK cells and NK/T cells incubated with IFN-␣ expressed CD69 equally strongly, with a time-and dose-dependence similar to that observed for CD8 ϩ T cells. However, in the presence of MPs, IFN-␣ only weakly induced CD69 in NK cells or NK/T cells. Histamine restored the IFN-␣-induced expression of CD69 in NK cells to the level observed in the absence of MPs (Table 1 ). In NK/T cells, histamine significantly restored the MP-induced inhibition of CD69 ( Table 2) . The effects of histamine on IFN-␣-induced expression of CD69 in cytotoxic lymphocytes were dose-dependent at final histamine concentrations of 0.1-50 M, with an ED 50 of ϳ2 M (see Fig. 2 ), i.e. similar to that previously reported for histamine H2 receptor (H2R)-mediated effects on leukocyte functions [28] (data not shown). Further, histamine-induced reversal of the T cell, NK cell, and NK/T cell anergy to IFN-␣ was completely antagonized by ranitidine, an antagonist at H2-type histamine receptors used at concentrations equimolar or tenfold lower than histamine (see Fig. 1 and not shown) . To exclude nonspecific effects of ranitidine, we used a ranitidine analog AH20399AA (C 13 H 22 O 4 ), in which the thioether group of ranitidine has been replaced by an ether, thereby reducing its affinity for H2R Ͼ 50-fold [12] . AH20399AA did not block the histamine effect (data not shown).
Role of ROS
Earlier studies have shown that MP-derived ROS induce dysfunction of NK cells and other cytotoxic lymphocytes and that histamine protects lymphocytes by suppressing or inhibiting ROS formation [12, 16, 28, 29] . To investigate whether the observed MP-induced inhibition of lymphocyte responsiveness to IFN was related to ROS production, we incubated lymphocytes and MPs with ROS production inhibitors and scavengers. DPI, an inhibitor of NADPH-oxidase activity in MPs [30] , was found to reverse the MP-induced inhibition of IFN-␣ activation in CD4 ϩ and CD8 ϩ T cells (Fig. 1, A-C ) and NK cells (Fig.  1D ). In addition, DPI is an inhibitor of nitric oxide synthetase (NOS) [30] , and MPs are known to produce reactive nitrogen intermediates of which NO and hydroxylnitrate are the ultimate effector-molecules. To clarify whether NO induction in MPs contributed to the observed T and NK cell anergy to IFN-␣, we used a specific NOS inhibitor, L-NAME. This compound, used at concentrations sufficient to inhibit NOS in MPs [24] , did not affect the MP-induced suppression of T cells, NK cells (data not shown), or NK/T cells (Fig. 2) .
Catalase, a scavenger of hydrogen peroxide [13] , significantly reversed the MP-induced inhibition of IFN-␣-induced CD69 expression in T cells and NK cells at concentrations exceeding 50 U/ml (Fig. 1, A-D) , whereas superoxide dismutase, a scavenger of superoxide anion [13] , was ineffective at concentrations sufficient to scavenge Ͼ90% of superoxide anion (200 U/ml; data not shown).
Apoptotic cell death in T cells and NK cells
In concordance with the results of an earlier report [16] , a large fraction of T and NK cells acquired a feature characteristic of apoptosis with a reduced forward-scatter and an increased right angle-scatter after overnight incubation with MPs ( Table 3) . Analyses of DNA fragmentation, Annexin V, and depleted intracellular glutathione [16] confirmed apoptosis in these cells. The three subsets of cytotoxic lymphocytes studied differed in their propensity of acquiring apoptotic features after incubation with MPs. Thus, NK/T cells were found to be intermediately sensitive and acquired characteristics of apoptosis to a lesser degree than NK cells but higher than T cells (Fig. 3) . The apoptosis in the NK/T cell population was studied in a presorted population, as some NK cells aquired unspecific binding of anti-CD3ε while undergoing apoptosis (data not shown), thereby confounding the analysis of apoptosis in NK/T cells. The sorting experiments also confirmed that NK cells were significantly more susceptible to apoptosis induction by MPs than CD3 ϩ /56 -T cells (Fig. 3) . IFN-␣ did not significantly alter the MP-induced apoptosis in T, NK, or NK/T cells. In accordance with earlier studies [29] , histamine, DPI, and catalase protected T, NK, and NK/T cells (Fig. 2, inset table) from MP-induced apoptosis. The same pattern was observed in IFN-␣-stimulated T, NK, and NK/T cells (Fig. 4 and data not shown) . To illustrate the impact of ROS for the IFN inducibility of cytotoxic lymphocytes, we calculated the number of viable, CD69-expressing lymphocytes with or without MPs and with or without histamine. This calculation revealed that IFN-␣ alone augmented the number of viable and activated CD4 ϩ T cells 9. ϩ T cells depends on an as-yet undefined interaction with MPs. Incubation with MPs was followed by apoptosis in all subsets of lymphocytes studied: CD4 ϩ , CD8 ϩ T cells, in CD56 ϩ NK cells, and CD56 ϩ /CD3ε ϩ NK/T cells. The lymphocyte anergy and apoptosis were apparently inflicted by ROS, as suggested by the findings that two inhibitors of ROS synthesis, histamine and DPI, and a scavenger of hydrogen peroxide, catalase, prevented the MP-induced nonresponsiveness and apoptosis.
These data suggest that ROS production by MPs limits the activation of cytotoxic cells by IFN-␣. Earlier studies show that cytokine-induced activation of NK cell-mediated cytotoxicity and proliferation is inhibited by MP-derived ROS, and MPs have been reported to inhibit IL-2-induced CD69 expression in several phenotype lymphocytes [12, 16, 31] . Our results confirm and extend these findings by demonstrating that an additional triggering pathway, IFN-␣ activation, is inhibited by MP-derived ROS.
The populations of lymphocytes studied showed different sensitivity against MP-induced, ROS-induced anergy and apoptosis. Earlier studies have revealed that NK cells are more sensitive to this suppressive mechanism than CD3ε ϩ T cells, as reflected by the finding that a higher frequency of NK cells became apoptotic after contact with ROS-producing MPs [16, 28] or after exposure to exogenously supplied hydrogen peroxide [13, 15, 28] . Our data extend this finding by demonstrating the following order of sensitivity to the ROS-mediated, apoptosis-inducing signal: NK cells Ͼ NK/T cells ϭ CD8 ϩ T cells Ͼ CD4 ϩ T cells. The mechanisms responsible for the differential sensitivity to MP-induced apoptosis in these cell populations remain to be defined.
In recent years, much attention has been directed toward the ability of MPs to adversely affect lymphocyte function [32] , and ROS generated by inflammatory MPs have been proposed to ϩ , CD56 ϩ , or CD3ε ϩ /CD56 ϩ cells. The sorted lymphocytes (150,000 cells/well in a total volume of 200 l) were incubated with MPs (150,000 cells/well 50% MP and 75,000 cells/well 25% MP; control) for 16 h at 37°C. Apopotosis was measured in indicated subsets of lymphocytes by use of flow cytometry scatter plots [16] . The data show the mean percentage of apoptosis Ϯ SEM in lymphocytes from the respective phenotype recovered from five blood donors. NK cells were significantly more sensitive to both ratios of monocytes tested than T cells, P Ͻ 0.01; or NK/T cells, P Ͻ 0.05. T cells, conversely, were significantly less sensitive to the highest monocyte ratio than NK/T cells, P Ͻ 0.05 (Mann-Whitney U-test).
account for a significant part of the dysfunction of tumor-killing lymphocytes in malignant diseases and in chronic viral infection [13, 19, 33, 34] . This mechanism of immunosuppression may be of particular relevance in liver tissue, which contains 80% of the host's MPs [35] . Furthermore, the production of ROS in hepatitis C virus (HCV)-infected liver tissue is reportedly enhanced by a factor of 50,000 [36] , possibly as the result of triggering of ROS formation by HCV-encoded proteins [37] . Therefore, our finding that NADPH-oxidase inhibitors and a scavenger of hydrogen peroxide protected IFN-␣-activated T cells, NK cells, and NK/T cells, which are assumed to participate in the eradication of HCV-infected cells [38] [39] [40] [41] , from MP-induced apoptosis and IFN-␣ nonresponsiveness may be applied therapeutically. One of these compounds, histamine dihydrochloride, is currently evaluated as an adjunct to IFN-␣ therapy in chronic hepatitis C [42] .
